文献速递肾移植

ASCENT试验实施情况:改善肾移植等待名单准入

Implementation of the ASCENT Trial to Improve Transplant Waitlisting Access.
PubMed 文献 · Kidney Int Rep · 2023-11-02

ASCENT研究为混合1型试验,纳入655家美国透析机构,评估多组分干预(员工网络研讨会、教育视频、机构反馈报告)的实施情况。331家(99%)完成调查,57%为高实施者,31%为低实施者,12%未实施。高实施机构中黑人新发患者的平均等待名单登记比例从基线0.83%升至1年1.40%,低实施机构从0.80%降至0.55%。

要点

  • 多组分干预在透析机构中实施率较高,57%为高实施者。
  • 高实施机构黑人新发患者等待名单登记比例1年时升高。
  • 访谈提示干预有助于机构优先安排移植教育。

核心结论

  • ASCENT干预在透析机构中实施程度不一,高实施与黑人新发患者等待名单登记比例改善相关。

研究设计与样本

  • 混合1型试验,纳入655家美国透析机构,干预组334家,实施后对331家(99%)进行调查并访谈6名机构员工。

主要发现

  • 331家完成调查的机构中,57%为高实施者,31%为低实施者,12%未实施。
  • 黑人新发患者低实施机构平均等待名单登记比例基线0.80%(95%CI 0.73-0.87),1年0.55%(95%CI 0.48-0.62);高实施机构基线0.83%(95%CI 0.78-0.88),1年1.40%(95%CI 1.35-1.45)。
  • 访谈显示干预帮助机构优先安排移植教育,但干预组分未统一分享。

关键数值与推荐

  • 高实施定义为使用3至4个干预组分,低实施为1至2个,未实施为0个。

临床怎么用

  • 在透析机构推广多组分干预时需关注实施 barriers 和 facilitators,以优化移植教育并提高等待名单准入。

局限性

  • 实施后调查仅覆盖干预组机构,访谈仅6名员工,结论需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The Allocation System for changes in Equity in Kidney Transplantation (ASCENT) study was a hybrid type 1 trial of a multicomponent intervention among 655 US dialysis facilities with low kidney transplant waitlisting to educate staff and patients about kidney allocation system (KAS) changes and increase access to and reduce racial disparities in waitlisting. Intervention components included a staff webinar, patient and staff educational videos, and facility-specific feedback reports. METHODS: Implementation outcomes were assessed using the Reach, Effectiveness, Adoption, Implementation, and Maintenance Framework. Postimplementation surveys were administered among intervention group facilities (n = 334); interviews were conducted with facility staff (n = 6). High implementation was defined as using 3 to 4 intervention components, low implementation as using 1 to 2 components, and nonimplementation as using no components. RESULTS: A total of 331 (99%) facilities completed the survey; 57% were high implementers, 31% were low implementers, and 12% were nonimplementers. Waitlisting events were higher or similar among high versus low implementer facilities for incident and prevalent populations; for Black incident patients, the mean proportion waitlisted in low implementer facilities was 0.80% (95% confidence interval [CI]: 0.73-0.87) at baseline and 0.55% at 1-year (95% CI: 0.48-0.62) versus 0.83% (95% CI: 0.78-0.88) at baseline and 1.40% at 1-year (95% CI: 1.35-1.45) in high implementer facilities. Interviews revealed that the intervention helped facilities prioritize transplant education, but that intervention components were not uniformly shared. CONCLUSION: The findings provide important context to interpret ASCENT effectiveness results and identified key barriers and facilitators to consider for future modification and scale-up of multilevel, multicomponent interventions in dialysis settings.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Urbanski M, Lee YH, Escoffery C, et al. Implementation of the ASCENT Trial to Improve Transplant Waitlisting Access. Kidney Int Rep. 2023. PMID: 38344743. doi:10.1016/j.ekir.2023.10.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。